Introduction {#s1}
============

Brucellosis is a zoonotic infectious disease caused by different species of the genus *Brucella*. One of the prevalent species in feral pigs and hares is *Brucella suis* with five different biovars. The biovars (bv) 1--3 infect mainly suidae, bv 4 infects reindeers and bv 5 is rarely found in rodents ([@R3], [@R8]). All of them possess a zoonotic potential, but only bv 1 and 3 seem to cause severe diseases in humans ([@R18]). In Europe the most common cause of porcine brucellosis is due to infections with *B. suis* bv 2, whereas bv 1 and 3 are reported in Croatia only once ([@R10], [@R6]). In most European countries feral pigs and hares seem to be the main reservoir for *B. suis* bv 2 ([@R10], [@R15], [@R17], [@R18], [@R13], [@R23]). Transmission to domestic pigs may occur through direct contact, sexual transmission or shared water reservoirs ([@R21]). The disease then causes infertility and abortion in female pigs and orchitis in male pigs. Furthermore, lymphadenitis, arthritis and subcutaneous abscesses may occur. Studies show that interactions between feral pigs and domestic pigs occur quite often ([@R23]). Regarding the growing populations of feral pigs in Europe this could explain the increase of infections in domestic pigs with brucellosis since 1990 ([@R12]). Therefore, brucellosis as a zoonotic disease is of great public health importance in many countries ([@R17], [@R11], [@R22]). Monitoring of *Brucella* spp. infections in domestic livestock and wild animals is mainly based on detection of antibodies specific for smooth lipopolysaccharide. This includes the risk of false positive reactions, especially for porcine brucellosis due to cross-reacting antibodies to the highly similar O-antigen of *Yersinia enterocolitica* O:9 ([@R14]). Additionally, non-reactors or animals which have not yet developed an antibody level can cause false negative results. During recent years PCR-based methods became more and more important as fast and reliable methods to detect *Brucella*-specific DNA from colony material or directly from field samples. On one hand conventional or real-time *Brucella* genus-specific PCR methods are used to identify brucellae from colony material or field samples ([@R5], [@R19]). On the other hand species-specific multiplex PCR techniques are implemented to differentiate on species level ([@R16]). Since real-time PCR is much more sensitive compared with conventional PCR it is often used to detect specific DNA in field samples directly. Obviously, a positive result in a genus-specific real-time PCR should be confirmed by a second method which ideally is a species-specific method. So far published real-time PCR methods are able to distinguish *B. abortus*, *B. melitensis* and *B. suis* bv 1 ([@R1]). In central Europe *B. suis* bv 2 is endemic in wild boar and hare populations and therefore influences monitoring of brucellosis at least in pig farms([@R10], [@R15], [@R18], [@R13], [@R23]). The last outbreaks of brucellosis in pigs in Germany were *B. suis* bv 2 infections in outdoor holdings which have been confirmed by isolation of the infectious agent ([@R17]).

The aim of this study was to develop a quantitative real-time PCR (qPCR) assay as a sensitive diagnostic tool for detection of *Brucella suis* bv 1--4. These biovars are the most prevalent and are of special epidemiological importance.

Materials and methods {#s2}
=====================

Bacterial strains and growth conditions {#s2a}
---------------------------------------

Bacteria used in this study are listed in [Tables 1](#VETRECO2014000084TB1){ref-type="table"} and [2](#VETRECO2014000084TB2){ref-type="table"}. A collection of 25 *Brucella* spp. reference strains, 75 *B. suis* field isolates and 30 closely related and clinically relevant non-*Brucella* species were obtained from the in house strain collection of the national reference laboratory for brucellosis (Friedrich-Loeffler-Institut, Germany). *Brucella* spp. strains were maintained on Brucella agar (Becton Dickinson) or Brucella agar, containing polymyxin B (2500 IE) bacitracin (12,500 IE), cyclohexymid (50 mg/l), nalidixic acid (2.5 mg/l), nystatin (50,000 IE) and vancomycin (10 mg/l), respectively ([@R7]). *Brucella* cultures were incubated with 5--10 per cent of CO~2~ at 37°C for 72 hours ([@R3]). All other bacterial strains were routinely cultivated on 5 per cent sheep blood agar (Becton Dickinson) or Luria Bertani agar (Fisher Scientific) overnight at 37°C.

###### 

Bacterial strains used in this study

  Bacterial species          Reference    Bacterial species                                   Reference
  -------------------------- ------------ --------------------------------------------------- ------------
  *Brucella* spp.                         Non-*Brucella* species                              
  *B. abortus* 544           ATCC 23448   *Actinobacillus pleuropneumoniae*                   ATCC 27088
  *B. abortus* S99                        *Bacillus brevis*                                   ATCC 8246
  *B. abortus* S19                        *Bacillus cereus*                                   ATCC 10876
  *B. abortus* 86/8/59       ATCC 23449   *Bacillus megaterium*                               ATCC 14581
  *B. abortus* Tulya         ATCC 23450   *Bacillus subtilis*                                 ATCC 6633
  *B. abortus* 292           ATCC 23451   *Bacillus thuringiensis*                            ATCC 10792
  *B. abortus* B3196         ATCC 23452   *Bordetella bronchiseptica*                         ATCC 19395
  *B. abortus* 870           ATCC 23453   *Burkholderia cepacia*                              DSM7288
  *B. abortus* C68           ATCC 23455   *Burkholderia mallei*                               ATCC 23344
  *B. melitensis* 16M        ATCC 23456   *Burkholderia pseudomallei*                         ATCC 23343
  *B. melitensis* Elberg                  *Escherichia coli*                                  DSM 30083
  *B. melitensis* 63/9       ATCC 23457   *Lactobacillus ruminis*                             DSM 20403
  *B. melitensis* Ether      ATCC 23458   *Mannheimia haemolytica*                            ATCC 33396
  *B. suis* 1330 (bv 1)      ATCC 23444   *Ochrobactrum anthropi*                             CCUG 1047
  *B. suis* Thomson (bv 2)   ATCC 23445   *Oligella urethralis*                               DSM 7531
  *B. suis* 686 (bv 3)       ATCC 23446   *Pasteurella multocida*                             DSM 5281
  *B. suis* 40 (bv 4)        ATCC 23447   *Pasteurella multocida subsp. multocida*            ATCC 43137
  *B. suis* 513 (bv 5)       NCTC 11996   *Proteus mirabilis*                                 ATCC 29906
  *B. canis* RM6/66          ATCC 23365   *Pseudomonas aeruginosa*                            ATCC 9027
  *B. ovis* 63/290           ATCC 25840   *Pseudomonas alcaligenes*                           ATCC 14909
  *B. neotomae* 5K33         ATCC 23459   *Pseudomonas fluorescens*                           ATCC 13525
  *B. ceti* B1/94            NCTC 12891   *Pseudomonas polymyxa*                              ATCC 842
  *B. pinnipedialis* B2/94   NCTC 12890   *Rhodococcus equi*                                  DSM 20307
  *B. microti* CCM4915       BCCN 07-01   *Staphylococcus aureus subsp. aureus*               ATCC 25178
  *B. inopinata* BO1         BCCN 09-01   *Stenotrophomonas maltophilia*                      ATCC 13637
                                          *Streptococcus agalactiae*                          ATCC 27956
                                          *Streptococcus equinus*                             ATCC 9812
                                          *Streptococcus parauberis*                          DSM 6631
                                          *Taylorella equigenitalis*                          DSM 10668
                                          *Yersinia enterocolitica* subsp. *enterocolitica*   ATCC 9610

ATCC, American Type Culture Collection; bv, biovar; BCCN, Brucella Culture Collection from Nouzilly; CCUG, Culture Collection, University of Göteborg; DSM, German collection of microorganisms (Deutsche Sammlung von Mikroorganismen); NCTC, National Collection of Type Culture

###### 

*B. suis* field isolates used in this study

  Biovar   Source of isolates   No. of isolates
  -------- -------------------- -----------------
  1        Feral pig            1
  2        Hare                 20
           Feral pig            32
           Domestic pig         21
  5        Human                1

Preparation of DNA templates {#s2b}
----------------------------

DNA was extracted from single colonies and resuspended in 200 µl of sterile distilled water after heat inactivation for two hours at 80°C. DNA isolation was carried out using the HighPure PCR Template Preparation Kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer\'s instructions for bacteria. DNA quantity and purity was determined using a NanoDrop™ 1000 spectrophotometer (Thermo Fisher Scientific, Wilmington, USA). Serial 1:10 dilutions ranging from 100 ng to 1 fg/µl of DNA were prepared for qPCR efficiency and specificity testing. DNA was also directly isolated from one *Brucella* culture-positive spleen sample from a hare with the same extraction kit according to the manufacturer\'s instructions for mammalian tissue. This was done as an example to show suitability of this assay for field samples.

Bioinformatic analyses {#s2c}
----------------------

For identification of a *B.* *suis*-specific target whole genome alignments were performed using the Geneious software (Geneious 6.0.3, Biomatters Ltd., Auckland, New Zealand). Genome sequences from various *Brucella* spp. ([Table 3](#VETRECO2014000084TB3){ref-type="table"}) were obtained from the NCBI GenBank database and analysed for *B. suis* bv 1 and 2 conserved regions. Identified targets were then tested for specificity using BLAST search with a Discontiguous Megablast against the NCBI GenBank database.

###### 

*Brucella* spp. genome sequences used for whole genome alignment analysis

  *Brucella* spp.      Accession no.\*
  -------------------- -----------------
  *B. abortus*         NC_016777
  * *                  NC_006933
  * *                  NC_007624
  *B. melitensis*      NC_003318
  * *                  NC_012442
  * *                  NC_017247
  * *                  NC_017245
  * *                  NC_017283
  *B. ovis*            NC_009504
  *B. canis*           NC_010104
  *B. microti*         NC_013118
  *B. pinnipedialis*   NC_015858
  *B. suis bv 1*       NC_017250
  *B. suis bv 2*       NC_010167
  *B. suis bv 3*       NZ_DS999731
  *B. suis bv 4*       NZ_GG703794
  *B. suis bv 5*       NZ_DS999712

\*NCBI GenBank accession number

Quantitative real time PCR {#s2d}
--------------------------

Oligonucleotides *B. suis* for 5′-GCC AAA TAT CCA TGC GGG AAG-3′ and *B. suis* rev 5′-TGG GCA TTC TCT ACG GTG TG-3′ targeting a 106 bp fragment of the BS1330_II0657 locus encoded on chromosome 2 of *B. suis* bv 1 with the FAM-labelled hydrolysis probe *B. suis* probe 6-carboxyfluorescein (FAM)-TTG CGC TTT TGT GAT CTT TGC GCT TTA TGG-BHQ1 were used for the qPCR detection assay (Jena Bioscience, Germany). Primer and probe were designed with Geneious software (Geneious 6.0.3, Biomatters Ltd., Auckland, New Zealand). For qPCR analysis the Stratagene Mx3000P QPCR System (Agilent Technologies, Santa Clara, USA) was used. The qPCR was performed in a 25 µl format using the 2× TaqMan Universal PCR Mastermix (Applied Biosystems, Foster City, California, USA), 0.3µM of each primer, 0.1µM probe and 2 µl of template DNA. The qPCR was carried out on an Mx3000P QPCR Instrument (Agilent Technologies, Santa Clara, California, USA) using the following cycling conditions: 50°C for 2 minutes, 95°C for 10 minutes and 50 cycles of 95°C for 15 seconds and 60°C for 1 minute. Data were analysed with the Mx3000Pro software. Raw data were normalised using an adaptive baseline correction and a smoothing with a moving average of three amplification points. Initially cycle threshold (C~t~) was set with background-based threshold algorithm. For better comparison of the results a threshold of 0.05 (dRn) was applied to all qPCR signals, as the highest of all computed thresholds from all experiments. Fluorescence signals above this value were considered as positive, below as negative results.

Determination of qPCR efficiency {#s2e}
--------------------------------

Standard curves were done with serial dilutions 1:10 from 10^6^ to 10^0^ fg/µl of bacterial DNA from *B. suis* bv 2. The efficiency of the PCR was calculated from the slope of the logarithmic regression of C~t~ values plotted against DNA concentrations by E=e^(−1/slope)−1^. For statistical analysis and assessment of reproducibility, standard curve experiments were done in quadruplicate and repeated five times on five different days. Additionally, qPCR efficiencies for *B. suis* bv 1--4 were compared by analysing serial dilutions 1:10 of genomic DNA from 10^6^ to 10^2^ fg/µl. Dilutions were chosen within the linear dynamic range of the assay and expected concentrations of DNA within possible specimens. Samples were analysed in duplicate.

Determination of the qPCR limit of detection {#s2f}
--------------------------------------------

The limit of detection (LOD) was defined as the DNA concentration with 95 per cent positive qPCR results. Therefore we used 100, 50, 25, 12.5 and 6.25 fg/µl of *B. suis* bv 2 DNA spiked into DNA preparations from anti-*Brucella* antibody and *Brucella* DNA-free swine sera. To proof *Brucella* DNA free status of the sera a published real-time PCR ([@R19]) was used as described. LOD samples were analysed in octuplicate for each concentration and repeated three times on three different days.

Capillary gel electrophoresis {#s2g}
-----------------------------

Real time PCR products were analysed by capillary gel electrophoresis using the QIAxcel DNA high resolution kit (1200) with an analytical range of 15 bp to 10 kb on the QIAxcel Advanced system (QIAGEN, Hilden, Germany). Briefly, 10 µl of each PCR product were added to the template tray and a standardised volume of 0.1 μl was injected automatically into the QIAxcel cartridge for analysis. For accurate fragment size determination the QX alignment marker 15 bp/3 kb and the QX DNA size marker FX174/HaeIII with a range of 50--1350 bp was used. Electrophoresic separation of amplicons was then carried out by applying the OM500 program. For data analysis and generation of a virtual gel image the Biocalculator QIAxcel software was used.

Results {#s3}
=======

Identification of a *B. suis* bv 1--4 specific qPCR target by whole genome comparison. {#s3a}
--------------------------------------------------------------------------------------

Annotated genome sequences from 12 *Brucella* spp. and *B. suis* bv 1 and 2 ([Table 3](#VETRECO2014000084TB3){ref-type="table"}) were analysed by whole genome comparison with *B. suis* bv 2 as reference genome. A region within the 3′ end of BS1330_II0657 locus was identified to be highly specific for *B. suis* with a 17 bp repeat exclusively found in *B. suis* bv 1--4 ([Fig 1](#VETRECO2014000084F1){ref-type="fig"}). All other *Brucella* spp. and *B. suis* bv 5 lack this repeat. Designed real-time primer were located up- and downstream of this repeat generating a 106 bp fragment for *B. suis* bv 1--4 and a 89 bp fragment for all other *Brucella* spp. and *B. suis* bv 5 ([Fig 2](#VETRECO2014000084F2){ref-type="fig"}). BLAST search performed for the 106 bp amplicon revealed 100 per cent complementarity for *B. suis* bv 1--4. The probe spanning the 17 bp repeat in *B. suis* bv 1--4 shows a 7 bp mismatch within the 5′-end in all other *Brucella* spp., lacking this repeat. However, this mismatch lowers the T~m~ to 57°C and prevents binding of the probe at the assay-specific annealing temperature of 60°C.

![Alignment of the targeted 3′ end of BS1330_II0657 locus from different *Brucella* spp. strains and *B. suis* bv 1--5. The alignment shows the 17 bp repeat specific for *B. suis* bv 1--4 and the resulting 7 bp mismatch of the probe (indicated by asterisks) for all other *Brucella* spp](vetreco2014000084f01){#VETRECO2014000084F1}

![High-resolution capillary gel electrophoresis of the *B. suis*-targeted quantitative real-time PCR amplicons. Primer *B. suis* for and *B. suis* rev were used for amplification of the targeted region within BS1330_II0657 locus. Lack of the 17 bp repeat in *Brucella* spp. or *B. suis* bv 5 are visualised and resulted in a fragment size of 106 bp for *B. suis* bv 1--4 and 89 bp for all other strains. Lane C2: Size marker; lane B1: *B. suis* bv 1; lane B2: *B. suis* bv 2; lane B3: *B. suis* bv 3; lane B4: *B. suis* bv 4; lane A5: *B. suis* bv 5; lane B10: *B. abortus* 544; lane A10: *B. melitensis* 16M; lane B9: *B. ovis*; lane B11: *B. canis*; lane A9: *B. microti*; lane A11: no template control](vetreco2014000084f02){#VETRECO2014000084F2}

PCR efficiency {#s3b}
--------------

For PCR efficiency determination genomic DNA standards from 10^6^ to 10^0^ fg/µl of *B. suis* bv 2 DNA were analysed. Efficiency was calculated from the slope and ranged between 90.8 and 97.6 per cent with a y-interception between 38.88 and 40.15 and a R^2^ value between 0.9821 and 0.9965 ([Fig 3](#VETRECO2014000084F3){ref-type="fig"}). Analysis of *B. suis* bv 1, 3 and 4 DNA standards revealed similar efficiencies of 94.3--95.5 per cent with y-intercepts between Ct- value 44.24 and 45.24 and an R^2^ value between 0.9567 and 0.9965 ([Fig 4](#VETRECO2014000084F4){ref-type="fig"}). In general we observed a decreasing accuracy, assessed as an increasing standard error (se) for the resulting C~t~ values with decreasing DNA concentrations. The se increased from 1 ng/µl to 10 fg/µl from 0.20 to 0.83 during the PCR efficiency testing and from 100 fg/µl to 12.5 fg/µl from 0.36 to 1 for the LOD determination ([Fig 5](#VETRECO2014000084F5){ref-type="fig"}).

![Logarithmic regression of quantitative real-time PCR efficiency testing experiments. Formulas show the slope values used for the efficiency calculation (slope ln). The values at the end of each formula show the y interceptions, which represent the theoretical maximal C~t~ values](vetreco2014000084f03){#VETRECO2014000084F3}

![Logarithmic regression of the *B. suis* bv 1--4 genomic DNA standards. Formulas show the slope values used for the efficiency calculation (slope ln). The values at the end of each formula show the y-interceptions, which represent the theoretical maximal C~t~ values](vetreco2014000084f04){#VETRECO2014000084F4}

![Scatter plot showing the increasing variation of C~t~ values with decreasing concentrations of *B. suis* bv 2 genomic DNA](vetreco2014000084f05){#VETRECO2014000084F5}

Limit of detection {#s3c}
------------------

The developed qPCR assay reproducibly detected 12.5 fg/µl of *B. suis* bv 2 DNA (3.7 bacterial genomes). At this DNA concentration all qPCR assays were 100 per cent positive. However, at a DNA concentration of 6.25 fg/µl (1.8 bacterial genomes), still 83 per cent of performed reactions were positive ([Fig 5](#VETRECO2014000084F5){ref-type="fig"}).

PCR specificity {#s3d}
---------------

To evaluate the specificity of the *B. suis* qPCR, DNA preparations from 30 non-*Brucella* species ([Table 1](#VETRECO2014000084TB1){ref-type="table"}), 25 *Brucella* spp. reference strains including five *B. suis* reference strains ([Table 1](#VETRECO2014000084TB1){ref-type="table"}), representing all five biovars were tested at a concentration of 100 pg/µl. For all 30 non-*Brucella* species negative results were obtained with C~t~ values not exceeding the calculated y-intercept from qPCR efficiency testing of 40 for any DNA concentration used (data not shown). Similar results were obtained for all *Brucella* spp. analysed. Only DNA from *B. suis* bv 1--4 strains showed positive results with C~t~ values of approximately 22. There were no suspicious or undefined signals for non-*B. suis* bv 1--4 samples ([Fig 6](#VETRECO2014000084F6){ref-type="fig"}). Furthermore we analysed 75 field isolates ([Table 2](#VETRECO2014000084TB2){ref-type="table"}) from confirmed *B. suis* cases from various animal species and geographical regions which were all qPCR positive for *B. suis* bv 1--4. One sample, which was a confirmed human case of *B. suis* bv 5 was tested negative.

![Amplification curves of *B. suis* bv 1--4 (100 pg/µl DNA) with C~t~ values from 22.08 to 22.52 and of *B. suis* bv 5, *B. abortus*, *B. melitensis* and *B. ovis* (1 ng/µl DNA). Raw data were processed with an adaptive baseline correction and a moving average of three amplification points. The threshold was set to 0.05 (dRn)](vetreco2014000084f06){#VETRECO2014000084F6}

Isolated DNA of the true positive spleen sample from the field was tested positive by *B. suis* qPCR also.

Discussion {#s4}
==========

The qPCR is a fast and reliable tool with still growing importance for direct detection of pathogens in clinical samples. For the diagnosis of brucellosis it has been already established and shown its usefulness. But till now and to the knowledge of the authors there is no description of a single probe qPCR that is able to detect all practically relevant *B. suis* bv 1--4. A test panel of overall 100 *Brucella* and 30 non-*Brucella* strains showed 100 per cent specificity of the new assay for *B. suis* bv 1--4. Our *B. suis* qPCR has an average efficiency of 95 per cent. This value shows its suitability for quantification of clinical samples even at very low concentrations of isolated DNA. A comparison of *B. suis* bv 1--4 showed no significant differences in C~t~-values for a serial dilution 1:10 from 1 ng/µl to 1 pg/µl of DNA. For the efficiencies calculated from standard curves only *B. suis* bv 4 showed a decreased value of 88 per cent whereas *B. suis* bv 1--3 had efficiencies of 93--94.5 per cent.

The limit of detecting was set at a concentration of 12.5 fg/µl of template DNA. This means the assay is able to detect three to four bacterial genomes in 1 µl of DNA isolated from clinical samples. To our knowledge this is the highest sensitivity reached with a *B. suis*-specific qPCR assay ([@R20], [@R4], [@R19], [@R2], [@R9]). Nevertheless we observed an increased variance of C~t~ values for DNA concentrations of 100 fg/µl down to the LOD with 12.5 fg/µl. We think the only reason for this is the growing impact of dilution errors and the resulting variance of used DNA for a single qPCR reaction. By spiking DNA into eluates from negative swine sera we also showed that the assay could be useful for diagnosis of clinical samples. DNA directly isolated from tissue of a spleen sample of one, by isolation proofed *Brucella* infected hare, was tested positive in the *B. suis* qPCR. To use the method for clinical samples like sera or biopsy material a true validation procedure has to be done.

A real-time PCR based single nucleotide polymorphism analysis (Gopaul and others 2008) differentiates *B. abortus*, *B. melitensis*, *B. ovis*, *B. suis*, *B. canis*, *B. neotomae* and marine *Brucella* spp. but with lower sensitivity than what seems to be necessary to examine field samples.

Regarding the problems with specificity and sensitivity in serology and the insufficient limits of detecting in most qPCR assays, this new assay could play a key role in improving the performance of large-scale brucellosis screenings of wild boar or hare populations and surveillance in domestic pigs.
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